Medican is in Negotiations to Obtain 51% of IHMML

By Business Wire,  June 30, 2014, 07:30:00 AM EDT


LAS VEGAS--(BUSINESS WIRE)-- Medican Enterprises, Inc. (OTCBB:MDCN) a bio-pharmaceutical company in the emerging global medical marijuana industry is pleased to announce it is currently negotiating the purchase of 51% of International Herbs Medical Marijuana Ltd ("IHMML"). Medican previously announced that they signed an agreement to obtain 50% of IHMML, but for consolidation purposes and increasing role undertaken by the IHMML management team, we are finalizing terms for a 51% acquisition. This will give Medican a controlling interest in IHMML and fits in well with our long-term vision to become a leader in the medical marijuana space.

Medican CEO Ken Williams stated, "the IHMML management team has taken an increasing role within the company and we are pleased to announce that Medican is finalizing discussions to obtain 51%."

About Medican Enterprises Inc.

Medican Enterprises is a bio-pharmaceutical company focused on developing, distributing and marketing pharmaceutical grade cannabis to the emerging global medical marijuana market. It's wholly owned subsidiary Medican Systems Inc. is an industry leader in the design, construction and operation of Medical Marijuana and Cultivation Centers across Canada and the United States. Traded on the OTCBB, Medican drives shareholder value through its scalable business model and commitment to scientific research, operational excellence and regulatory compliance. For more information visit: www.medicaninc.com.

Forward-Looking and Cautionary Statements

Certain statements contained herein contain "forward-looking statements" within the meaning of Section 27A of Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements involve known and unknown risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medican Enterprises Inc. to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Medican Enterprises Inc. disclaims any obligation to update or to announce publicly the results of any revision of the forward-looking statements contained or incorporated by reference herein to reflect future events or developments. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.

Source: Medican Enterprises, Inc.



This article appears in: News Headlines

Referenced Stocks: MDCN


Latest News Video





Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.09 0.08 ▲ 0.50%
AAPL $ 102.50 0.25 ▲ 0.24%
PBR $ 19.57 0.45 ▲ 2.35%
TWTR $ 49.75 0.32 ▲ 0.65%
INTC $ 34.92 0.27 ▲ 0.78%
SIRI $ 3.63 0.03 ▲ 0.83%
VALE $ 13.06 0.05 ▼ 0.38%
FB $ 74.82 0.97 ▲ 1.31%

As of 8/29/2014, 04:04 PM